Analysis of the risk factors for recurrence of gastrointestinal stromal tumors after resection

VernacularTitle:胃肠道间质瘤切除术后复发危险因素的初步研究
Author: Jingshan HUANG ; Xuegong SUN ; Zhaoran SU ; Guihe WANG
Publication Type:Journal Article
Keywords: Gastrointestinal stromal tumors; Surgical treatment; Diagnosis; Risk factor
From: International Journal of Surgery 2012;39(3):171-173
CountryChina
Language:Chinese
Abstract: ObjectiveTo investigate the postoperative risk factors for gastrointestinal stromal tumors.MethodsFrom December 2005 to December 2010,sixty-one gastrointestinal stromal tumors patients of People' s Hospital of Tongling city gastrointestinal surgery department were analyzed retrospectively.Using the logistic regression model to calculate the postoperative recurrence risk factors. Results Sixty-one patients underwent operation,including gastrectomy (40 cases ),partial intestina parva resection (7 cases),partial colon resection ( 3 cases ),Dixon' s operation ( 2 cases ) and tumorectomy ( 9 cases ).Fifteen patients were given postoperative imatinib Mesylate Capsules (Glivec) treatment.Fifty-seven patients were followed-up more than 1 year and 7 cases were found palindromia ( 12％ ).Logistic model shows that the malignant degree of gastrointestinal stromal tumors is the only risk factor of postoperative palindromia.ConclusionsMalignant degree of gastrointestinal stromal tumors is the main risk factor for postoperative palindromia.Imatinib mesylate capsules treatment may be beneficial to the greater stage patients.